Related Experiment Video
Updated: Aug 8, 2026

Synthesis of a Deuterated Standard for the Quantification of 2-Arachidonoylglycerol in Caenorhabditis elegans
Published on: September 21, 2019
Endocannabinoids in the central nervous system--an overview
1Department of Behavioral Sciences, College of Judea and Samaria, Ariel, 44837 Israel. fride@research.yosh.ac.il
The endocannabinoid system, including anandamide, plays key roles in brain function and physiological processes. Inhibiting fatty acid amide hydrolase (FAAH) offers therapeutic potential for cannabinoid-related activities.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Anandamide, the first identified endocannabinoid, and other related compounds like 2-arachidonoyl glycerol and noladin ether, have been extensively studied since 1992.
- Endocannabinoids are synthesized, released, and metabolized in the brain, primarily via fatty acid amide hydrolase (FAAH).
- Their pharmacological effects resemble, but are not identical to, plant-derived and synthetic cannabinoid receptor ligands.
Purpose of the Study:
- To review the physiology and pharmacology of endocannabinoids.
- To explore the therapeutic potential of targeting the endocannabinoid system, particularly through FAAH inhibition.
- To discuss the involvement of endocannabinoids in various physiological functions and potential applications.
Main Methods:
- Literature review of studies on endocannabinoid physiology and pharmacology.
- Analysis of endocannabinoid synthesis, release, reuptake, and hydrolysis mechanisms.
- Examination of interactions with other receptor systems and their physiological implications.
Main Results:
- Endocannabinoids are widely distributed in the brain, involved in neuronal signaling.
- FAAH inhibitors show promise for targeted cannabinoid therapies.
- Endocannabinoid system influences pain, motor control, learning, reward, and appetite.
Conclusions:
- Endocannabinoid system is crucial for central nervous system functions and physiological regulation.
- Targeting FAAH may offer a more specific therapeutic approach than direct cannabinoid agonists.
- The endocannabinoid system's role in appetite and infant survival presents potential therapeutic applications for wasting diseases and failure to thrive.
Related Concept Videos
Neurochemical Transmission: Sites of Drug Action
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Opioid Receptors: Overview
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
An Overview of Psychoactive Drugs
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...

